Board of Directors have approved the re-appointment of Mr. Arvind Vilasrao Sapkal (DIN: 08607096) as a non executive independent director for a second term of Five consecutive years, subject to the approval of shareholders of the Company.
Ishita Drugs & Industries Ltd. Press Release Aug 12 2025
Filed with BSE · · 7 pages · English
Release
Ishita Drugs & Industries Ltd. on 6ix
Earlier from Ishita Drugs & Industries
- Ishita Drugs & Industries Ltd. Press Release Aug 06 2025
- Ishita Drugs & Industries Ltd. Press Release Jul 08 2025
- Ishita Drugs & Industries Ltd. Press Release Jun 27 2025
- Ishita Drugs & Industries Ltd. Press Release Jun 25 2025
- Ishita Drugs & Industries Ltd. Press Release Jun 13 2025
Later from Ishita Drugs & Industries
- Ishita Drugs & Industries Ltd. Press Release Aug 28 2025
- Ishita Drugs & Industries Ltd. Press Release Aug 30 2025
- Ishita Drugs & Industries Ltd. Press Release Sep 02 2025
- Ishita Drugs & Industries Ltd. Press Release Sep 05 2025
- Ishita Drugs & Industries Ltd. Press Release Sep 17 2025
Follow Ishita Drugs & Industries into a list and get an email when it puts out news.
Follow Ishita Drugs & Industries